Potential role of Anxa1 in cancer.
暂无分享,去创建一个
[1] M. Festa,et al. The Involvement of Xanthohumol in the Expression of Annexin in Human Malignant Glioblastoma Cells , 2013, The open biochemistry journal.
[2] Y. Jeng,et al. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma , 2008, Journal of surgical oncology.
[3] M. Hickey,et al. Deficiency of Annexin A1 in CD4+ T Cells Exacerbates T Cell–Dependent Inflammation , 2013, The Journal of Immunology.
[4] N. Hu,et al. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma , 2006, BMC Cancer.
[5] S. Nelson,et al. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. , 2004, Biochemical and biophysical research communications.
[6] Yanqing Ding,et al. Protein and mRNA Characterization in Human Colorectal Carcinoma Cell Lines with Different Metastatic Potentials , 2007, Cancer investigation.
[7] M. Schuliga,et al. Annexin‐1 signals mitogen‐stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] M Dietel,et al. Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells. , 1998, Journal of biochemical and biophysical methods.
[9] Sindeval José da Silva,et al. Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients. , 2010, Oral oncology.
[10] A. Rosengarth,et al. X-ray structure of full-length annexin 1 and implications for membrane aggregation. , 2001, Journal of molecular biology.
[11] S. Moss,et al. Annexins: from structure to function. , 2002, Physiological reviews.
[12] Nan Hu,et al. 2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers* , 2002, Molecular & Cellular Proteomics.
[13] Ming-Tsan Lin,et al. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal‐regulated kinase/integrin beta‐1‐binding protein 1 pathway , 2012, Cancer.
[14] S. Oliani,et al. Expression of Annexin-A1 and Galectin-1 Anti-Inflammatory Proteins and mRNA in Chronic Gastritis and Gastric Cancer , 2013, Mediators of inflammation.
[15] S. Hanash,et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] M. Sun,et al. The association of annexin A2 and cancers , 2012, Clinical and Translational Oncology.
[17] R. Gillet,et al. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin iii sv40 t large antigen transgenic mice , 2000, Hepatology.
[18] L. Márk,et al. Mass Spectrometry-Based Salivary Proteomics for the Discovery of Head and Neck Squamous Cell Carcinoma , 2012, Pathology & Oncology Research.
[19] K. T. Patton,et al. Decreased annexin I expression in prostatic adenocarcinoma and in high‐grade prostatic intraepithelial neoplasia , 2005, Histopathology.
[20] J. Turnay,et al. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5 , 2005, Journal of cellular biochemistry.
[21] Yuanbo Kou,et al. Annexin A1 mediates the anti‐adhesive effects of dexamethasone during the cell–cell interaction between the all‐trans retinoic acid‐treated acute promyelocytic leukemic cells and endothelial cells , 2013 .
[22] Zhuchu Chen,et al. Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis , 2008, Clinical Cancer Research.
[23] S. Leow,et al. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis , 2011, Oncogene.
[24] Steve Goodison,et al. Proteomic profiling identifies breast tumor metastasis‐associated factors in an isogenic model , 2007, Proteomics.
[25] Keli Ou,et al. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. , 2008, Journal of proteome research.
[26] X. Yang,et al. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[27] Yankai Xia,et al. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer , 2007, Proteomics.
[28] José Vassallo,et al. Overexpression of ANXA1 in Penile Carcinomas Positive for High-Risk HPVs , 2013, PloS one.
[29] A. Pinchera,et al. Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. , 2008, Journal of proteome research.
[30] Sung-Wuk Jang,et al. The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells. , 2012, Biochemical and biophysical research communications.
[31] D. Noh,et al. Clinical Significance of Annexin A1 Expression in Breast Cancer , 2011, Journal of breast cancer.
[32] Ming-Rong Wang,et al. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas , 2002, Oncogene.
[33] S. Ryozawa,et al. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. , 2011, Anticancer research.
[34] G. Stassi,et al. Annexin-1 downregulation in thyroid cancer correlates to the degree of tumour differentiation , 2006, Cancer biology & therapy.
[35] S. Mussunoor,et al. The role of annexins in tumour development and progression , 2008, The Journal of pathology.
[36] Sylvia E. Le Dévédec,et al. Annexin A1 regulates TGF-β signaling and promotes metastasis formation of basal-like breast cancer cells , 2010, Proceedings of the National Academy of Sciences.
[37] F. D’Acquisto,et al. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation , 2009, Nature Reviews Immunology.
[38] Li‐yu Lee,et al. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray. , 2006, Oncology reports.
[39] K. Kumamoto,et al. Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis. , 2011, Experimental and therapeutic medicine.
[40] D. Ornstein,et al. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells , 2006, The Prostate.
[41] J. Vishwanatha,et al. Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines , 2004, BMC Cancer.
[42] B. Zhu,et al. Identification of Cervical Cancer Proteins Associated With Treatment With Paclitaxel and Cisplatin in Patients , 2011, International Journal of Gynecologic Cancer.
[43] David Chia,et al. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. , 2006, Human pathology.
[44] P. Wong,et al. Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[45] D. Ornstein,et al. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[46] Yu Jin,et al. Green tea induces annexin-I expression in human lung adenocarcinoma A549 cells: involvement of annexin-I in actin remodeling , 2007, Laboratory Investigation.
[47] T. Deguchi,et al. A Comparative Study of Protein Profiling by Proteomic Analysis in Camptothecin-Resistant PC3 and Camptothecin-Sensitive LNCaP Human Prostate Cancer Cells , 2006, Urologia Internationalis.
[48] P R Taylor,et al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. , 2000, Cancer research.
[49] H. Beug,et al. Annexin A1 attenuates EMT and metastatic potential in breast cancer , 2010, EMBO molecular medicine.
[50] G. Murray,et al. Characterisation and protein expression profiling of annexins in colorectal cancer , 2007, British Journal of Cancer.
[51] M. Fresno,et al. Down-regulation of annexin A1 and A2 protein expression in intestinal-type sinonasal adenocarcinomas. , 2011, Human pathology.
[52] Alice Lau,et al. Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling. , 2009, Carcinogenesis.
[53] Manuel D. Díaz-Muñoz,et al. A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretion. , 2009, Cancer Research.
[54] E. Tajara,et al. Annexin 1: Differential expression in tumor and mast cells in human larynx cancer , 2007, International journal of cancer.
[55] Peng-Fei Zhang,et al. Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma , 2011, Clinical & Experimental Metastasis.
[56] N. Xu,et al. A proteomic investigation into a human gastric cancer cell line BGC823 treated with diallyl trisulfide. , 2006, Carcinogenesis.
[57] Peng-Yuan Yang,et al. Identification and analysis of altered α1,6‐fucosylated glycoproteins associated with hepatocellular carcinoma metastasis , 2006 .
[58] Ying Wang,et al. Annexin-I expression modulates drug resistance in tumor cells. , 2004, Biochemical and biophysical research communications.
[59] O. Krakovska,et al. Identification of Novel Molecular Targets for Endometrial Cancer Using a Drill-Down LC-MS/MS Approach with iTRAQ , 2011, PloS one.
[60] M. Toth,et al. Elevated Levels of Annexin I Protein in vitro and in vivo in Rat and Human Mammary Adenocarcinoma , 1998, Clinical & Experimental Metastasis.
[61] G Parmigiani,et al. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer , 2008, Oncogene.
[62] J. Turnay,et al. Upregulation of Annexin A1 Expression by Butyrate in Human Colon Adenocarcinoma Cells: Role of p53, NF-Y, and p38 Mitogen-Activated Protein Kinase , 2008, Molecular and Cellular Biology.
[63] X. Xu,et al. Increased expression of annexin A1 is correlated with K-ras mutation in colorectal cancer. , 2010, The Tohoku journal of experimental medicine.
[64] H. An,et al. Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells. , 2010, Journal of proteome research.
[65] S. Venz,et al. Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome. , 2007, Histology and histopathology.
[66] N. Wu,et al. The role of annexin A3 playing in cancers , 2013, Clinical and Translational Oncology.
[67] Concepcion R. Diaz-Arrastia,et al. Implications of tyrosine phosphoproteomics in cervical carcinogenesis , 2008, Journal of carcinogenesis.
[68] J. Rodrigo,et al. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. , 2004, The American journal of pathology.
[69] R. Layfield,et al. Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. , 2009, European journal of cancer.
[70] S. Zucoloto,et al. Myenteric denervation in gastric carcinogenesis: differential modulation of nitric oxide and annexin-A1. , 2013, International journal of clinical and experimental pathology.
[71] B. Fontanella,et al. Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1. , 2010, Cancer letters.
[72] M. Hande,et al. Annexin-1 protects MCF7 breast cancer cells against heat-induced growth arrest and DNA damage. , 2010, Cancer letters.
[73] V. Gerke,et al. Structural basis of the Ca(2+)-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. , 2000, Structure.
[74] Katrin Trautmann,et al. Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival , 2009, Modern Pathology.
[75] S. Marullo,et al. A novel calcium‐dependent proapoptotic effect of annexin 1 on human neutrophils , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[76] A. Karkhane,et al. Proteomics of a new esophageal cancer cell line established from Persian patient. , 2012, Gene.
[77] S. Baldus,et al. Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma , 2010, Proteomics.
[78] Chuanbing Shi,et al. Up-regulation of hnRNP A1, Ezrin, tubulin β-2C and Annexin A1 in sentinel lymph nodes of colorectal cancer. , 2010, World journal of gastroenterology.
[79] S. Zeng,et al. Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study. , 2009, Omics : a journal of integrative biology.
[80] T. Putti,et al. Annexin-1 Regulates Growth Arrest Induced by High Levels of Estrogen in MCF-7 Breast Cancer Cells , 2009, Molecular Cancer Research.
[81] H. Aburatani,et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. , 2001, Cancer research.
[82] D. Ornstein,et al. Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. , 2004, Journal of Urology.
[83] M. Perretti,et al. Annexin I Regulates SKCO-15 Cell Invasion by Signaling through Formyl Peptide Receptors* , 2006, Journal of Biological Chemistry.
[84] G. Chang,et al. Annexin A1 expression and its prognostic significance in human breast cancer. , 2010, Neoplasma.
[85] K. Nan,et al. Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2 , 2012, Medical Oncology.
[86] J. Rao,et al. Annexin‐I as a potential target for green tea extract induced actin remodeling , 2007, International journal of cancer.
[87] G. Casey,et al. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells , 2004, Clinical & Experimental Metastasis.
[88] Y. Yang,et al. Decreased Expression of Annexin A1 during the Progression of Cervical Neoplasia , 2008, The Journal of international medical research.
[89] Xiaohang Zhao,et al. Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma. , 2003, World journal of gastroenterology.
[90] D. Wang,et al. Annexin-1 Downregulation Is Associated with Clinical Outcome in Chinese Patients with Hilar Cholangiocarcinoma , 2010, European Surgical Research.
[91] Li Mao,et al. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry , 2004, Clinical & Experimental Metastasis.
[92] J. Clifton,et al. Identification of members of the annexin family in the detergent-insoluble fraction of rat Morris hepatoma plasma membranes. , 2006, Journal of chromatography. A.
[93] Zhuchu Chen,et al. Preliminary proteomic analysis of indomethacin's effect on tumor transplanted with colorectal cancer cell in nude mice. , 2006, Journal of biochemistry and molecular biology.
[94] K. Uzawa,et al. Down-regulation of plasma membranous Annexin A1 protein expression in premalignant and malignant lesions of the oral cavity: correlation with epithelial differentiation , 2009, Journal of Cancer Research and Clinical Oncology.
[95] A. Moser,et al. The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage , 2007, Laboratory Investigation.
[96] A. Rashid,et al. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers , 2008, Oncogene.
[97] Fang Liu,et al. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. , 2004, World journal of gastroenterology.
[98] F. Kokocinski,et al. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development , 2006, Oncogene.
[99] Katia Basso,et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1) , 2004, The Lancet.
[100] A. Tosco,et al. Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1. , 2008, European journal of cancer.
[101] K. Uzawa,et al. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. , 2005, International journal of oncology.
[102] M. Sakaguchi,et al. Truncation of Annexin A1 Is a Regulatory Lever for Linking Epidermal Growth Factor Signaling with Cytosolic Phospholipase A2 in Normal and Malignant Squamous Epithelial Cells* , 2007, Journal of Biological Chemistry.
[103] M. Henry,et al. Proteomic analysis of multidrug‐resistance mechanisms in adriamycin‐resistant variants of DLKP, a squamous lung cancer cell line , 2009, Proteomics.
[104] U. Rescher,et al. Disruption of the annexin A1/S100A11 complex increases the migration and clonogenic growth by dysregulating epithelial growth factor (EGF) signaling. , 2013, Biochimica et biophysica acta.
[105] Shazib Pervaiz,et al. Annexin 1: the new face of an old molecule , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[106] Ting-feng Wu,et al. Search for the tumor‐related proteins of transition cell carcinoma in Taiwan by proteomic analysis , 2006, Proteomics.
[107] Ting-feng Wu,et al. Annexin‐I overexpression is associated with tumour progression and independently predicts inferior disease‐specific and metastasis‐free survival in urinary bladder urothelial carcinoma , 2010, Pathology.
[108] Y. Wong,et al. Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan. , 2010, Journal of the Formosan Medical Association = Taiwan yi zhi.
[109] Qiang Li,et al. Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer , 2008, Clinical & Experimental Metastasis.
[110] J. Maublant,et al. Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. , 2009, Biochimica et biophysica acta.
[111] Kazuyuki Nakamura,et al. Identification of differentially expressed proteins in tumour necrosis factor-alpha-resistant and -sensitive rat hepatoma cells. , 2011, Anticancer research.
[112] J. Chiu,et al. GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[113] V. Gerke,et al. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. , 2000, Molecular cell.
[114] K. Monastyrskaya,et al. The annexins: spatial and temporal coordination of signaling events during cellular stress , 2009, Cellular and Molecular Life Sciences.
[115] Yun Wu,et al. Loss of Annexin A1 Expression in Breast Cancer Progression , 2008, Applied immunohistochemistry & molecular morphology : AIMM.
[116] B. Yi,et al. Annexin A1 protein regulates the expression of PMVEC cytoskeletal proteins in CBDL rat serum-induced pulmonary microvascular remodeling , 2013, Journal of Translational Medicine.
[117] Rong Biaoxue,et al. Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients , 2012, Journal of experimental & clinical cancer research : CR.
[118] F. D’Acquisto,et al. Pro-inflammatory and pathogenic properties of Annexin-A1: the whole is greater than the sum of its parts. , 2013, Biochemical pharmacology.